Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done for biopharma and medtech companies.

Walk with us. Together, we’ll build lasting value.

Learn more

 

 

Latest Transactions

Regenacy

Chinese joint venture to facilitate indication expansion opportunity, December 2020

TWiB

Japan collaboration for a phase 2 orphan dermatology asset AC-203, a novel topical treatment for epidermolysis bullosa simplex, December 2020

Nevakar

Nevakar and Zhaoke Ophthalmology enter into licensing agreement for NVK-002, October 2020

 

 

 

arrows-right-blueCapabilities

Corporate, R&D, BD, and financing strategy and commercial analytics with strategic transactions and capital markets execution

arrows-right-orangeGeographies

Global reach with on-the-ground local presence and company and investor relationships in all major life science markets 

arrows-right-tealApproach

Integration of upfront preparation with downstream execution with a transaction lens

Each quarter we compile key statistics and trends on strategic transactions and financings.

You can download your report here.

Each quarter we compile key statistics and trends on strategic transactions and financings.

You can download your report here.

Each quarter we compile key statistics and trends on strategic transactions and financings.

You can download your report here.

Our Transactions

Locust Walk has closed high value transactions for multiple clients across a variety of therapeutic areas and modalities. The breadth of our success includes sell-side, buy-side and financing deals. Examples of recent client engagements where Locust Walk served as a transaction advisor are listed below. We would encourage you to click on each case study and/or press release to learn about each assignment in greater detail.

VIEW OUR CASE STUDIES »

Securities offered through Locust Walk Securities, LLC, member FINRA/SIPC.